These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Antiviral activity and resistance of HCV NS5A replication complex inhibitors. Gao M Curr Opin Virol; 2013 Oct; 3(5):514-20. PubMed ID: 23896281 [TBL] [Abstract][Full Text] [Related]
17. [Research progress of HCV NS5A complex inhibitors]. Jiang XB; Li YP; Li ZR Yao Xue Xue Bao; 2016 Sep; 51(9):1378-87. PubMed ID: 29924511 [TBL] [Abstract][Full Text] [Related]
18. Synergistic Activity of Combined NS5A Inhibitors. O'Boyle DR; Nower PT; Gao M; Fridell R; Wang C; Hewawasam P; Lopez O; Tu Y; Meanwell NA; Belema M; Roberts SB; Cockett M; Sun JH Antimicrob Agents Chemother; 2015 Dec; 60(3):1573-83. PubMed ID: 26711745 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of antiviral effects of novel NS5A inhibitors in hepatitis C virus cell culture system with full-genome infectious clones. Murayama A; Fujiwara K; Yamada N; Shiina M; Aly HH; Masaki T; Muramatsu M; Wakita T; Kato T Antiviral Res; 2018 Oct; 158():161-170. PubMed ID: 30118732 [TBL] [Abstract][Full Text] [Related]
20. HCV Genotype 6a Escape From and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models. Pham LV; Ramirez S; Gottwein JM; Fahnøe U; Li YP; Pedersen J; Bukh J Gastroenterology; 2018 Jun; 154(8):2194-2208.e12. PubMed ID: 29454794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]